Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS
Clinical trial NCT00574548 · COMPLETED
Trial details
- NCT number
- NCT00574548
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2010-02-01
- Enrollment
- 720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.